Introduction {#s1}
============

The use of amphetamine-type stimulants (ATS) is recognized as a major global public health problem [@pone.0060544-Marshall1]. The 2012 World Drug Report showed that the ATS is the second leading substance of abuse following cannabis worldwide, with estimates that up to 52 million individuals (1.2% of the global population aged 15--64 years) have used ATS at least once in the past 12 months [@pone.0060544-United1]. East-south Asia have experienced significant increase of ATS use, particularly among young people [@pone.0060544-United2]. In China, the main element of new synthetic drugs emerged recent years is ATS which including methamphetamine (MA), methylenedioxymethamphetamine (MDMA), and so-called "Magu" pills (which are typically capsules containing a mixture of MA and other drugs such as caffeine) [@pone.0060544-Liu1], [@pone.0060544-National1]. Data from the China National Narcotic Control Commission showed that 59,500 people used or abused synthetic drug in 2005, accounting for 6.7% of registered drug users [@pone.0060544-National2]. However, by the end of 2011, this number had swelled to an estimated 0.59 million people (32.7% of the 1.79 million registered drug users) and among them 67.8% were under 35 year's young people [@pone.0060544-National1].

Depression often co-occurs with amphetamine type stimulants use and the link between ATS use and depression has been reported in previous studies [@pone.0060544-Liu1], [@pone.0060544-Zweben1], [@pone.0060544-Sutcliffe1]. Our early studies showed that the most ATS users had suffered from psychosis comorbidity, and one of the main syndromes was depression [@pone.0060544-Liu1]. An Australia study showed that 79% methamphetamine users reported history of depression, and an American epidemiological data showed 41.6% of adults with amphetamine use disorders have a lifetime history of depression [@pone.0060544-Conway1], [@pone.0060544-Hall1]. Recent years, some studies focus on the temporal relationship between depression and ATS use, a prospective cohort study from Australia indicated that ATS initiation during adolescence was associated with adulthood depression, whereas early depression was not predictive of future ATS use [@pone.0060544-Degenhardt1]. Some studies showed that the patients seeking treatment for ATS dependence are more likely to be diagnosed with depression [@pone.0060544-McKetin1]. The factors related drug use were reported to be associated with depression, such as early onset ATS use (initiation use at 15 years or younger), the administration of injection and more frequent (≥4 days per week) ATS use [@pone.0060544-Zweben1], [@pone.0060544-Yen1], [@pone.0060544-Celentano1]. Depression have controversial association with cessation of ATS use, a study indicated that depression is a major component of the withdrawal syndrome of ATS use during the first 3 weeks of abstinence [@pone.0060544-McGregor1], however an prospective cohort study found that depressive symptoms decreased significantly among those who stopped using ATS over the 12-month study period [@pone.0060544-Sutcliffe1].

With the dramatically increase of ATS users in China, the public health burden of psychiatric co-morbidities associated with ATS use may have increased. However, little is known about the status and associations of depression among ATS users in China. This study aims to find the relation between pattern of ATS use and the depressive symptoms and to examine its potential associated factors among this population in China. Such findings would provide information for the treatment and management strategies for ATS use and associated mental health in this population.

Materials and Methods {#s2}
=====================

Ethics Statement {#s2a}
----------------

This research protocol was approved by the Institutional Review Board of Peking University Health Center and written informed consent was obtained from all study participants. At each study site, the trained interviewers explained the meaning and aim of the survey to the potential participants and let them to know that this is a scientific study which would keep secret information for all participants before the investigation in a separate room. Because the participants in compulsory drug detoxification center belong to a traditionally vulnerable group, the interviewers explained the detailed process of investigation and make sure that all potential participants who declined to participate or otherwise did not participate were not disadvantaged in any other way by not participating in the study. If the potential participants did not clearly understand, interviewers explained again. After they understand the study completely and signed informed consent, the face-to-face interviews were conducted by trained interviewers using a self-administered structured questionnaire that included demographic characteristics, drug use history, general information of cigarette smoking, drinking behavior and depression.

Participants and Setting {#s2b}
------------------------

A cross-sectional study of depression and risk behavior among ATS users was conducted in compulsory and voluntary drug detoxification and rehabilitation centers in Beijing and Guangdong Province from March 2010 to August 2010. The study design used convenience sampling to recruit any patients who meet study inclusion criteria: (1) at least 18 years old, (2) urine test positive for at least one of ATS drug, including MA, "Magu" pills (the main component of which is MA), and MDMA, at the time they entered the detoxification center, and (3) meeting the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association) criteria for ATS abuse or dependence, and (4) signed informed consent. The participants were excluded if they had serious physical illnesses such as an acute stage of cardiovascular disease, cerebrovascular disease, or neurodegenerative diseases.

Measures and Test {#s2c}
-----------------

At each study site, the trained interviewers explained the meaning and aim of the survey to the potential participants and let them to know that this is a scientific study which would keep secret information for all participants before the investigation in a separate room. Because the participants in compulsory drug detoxification center belong to a traditionally vulnerable group, the interviewers explained the detailed process of investigation and make sure that all potential participants who declined to participate or otherwise did not participate were not disadvantaged in any other way by not participating in the study. If the potential participants did not clearly understand, interviewers explained again. After they understand the study completely and signed informed consent, the face-to-face interviews were conducted by trained interviewers using a self-administered structured questionnaire that included demographic characteristics, drug use history, general information of cigarette smoking, drinking behavior and depression. The demographic variables included gender, age, ethnicity, education, marital status, and employment. Questions about drug use history investigated the types of ATS ever used and the main type of drug use, frequency, duration, and administration of ATS use. Cigarette smoking and nicotine dependence were collected by the Fagerström Test for Nicotine Dependence (FTND) [@pone.0060544-Heatherton1]. Symptoms of depression were measured using the short 13-item Beck Depression Inventory (BDI-13). Each item is scored from 0 to 3 with a maximum score of 39. The score of 0--4, 5--7, 8--15, ≥16 were classified as no depression, mild, moderate and severe depression respectively [@pone.0060544-Beck1], [@pone.0060544-Subramaniam1]. Participants self-administered the BDI under the supervision of a research staff who read the questions aloud for those who requested help or had difficulty reading during interview.

Statistical Analysis {#s2d}
--------------------

The data were double entered, and the consistency of both databases was compared using Epi Data software (Epi Data Association, Odense, Denmark). The estimations of the means and proportions were calculated to describe the demographic characteristics, drug use history, cigarette smoking, nicotine dependence, alcohol drinking, BDI score and prevalence of depressive symptoms. Pearson chi-square test and bivariate logistic regression were used for the analysis of demographic characteristics, drug use history, cigarette smoking and alcohol drinking with different depression status. A multiple logistic regression model was constructed using a stepwise backward sequence. All variables that were significantly associated with the endpoint based on the univariate logistic regression were then entered in a multiple logistic regression model to adjust for all other variables. Potential confounding effects and effect modification were examined for: current age, education level, occupation etc. All analyses were performed using SAS software, version 9.1 (SAS Institute, Cary, NC). Statistically significant findings were determined using a 2-tailed P value of 0.05.

Results {#s3}
=======

Sample Characteristics and Pattern of Drug Use {#s3a}
----------------------------------------------

Among 402 eligible participants, 202 participants were recruited from the compulsory drug detoxification and rehabilitation center in Beijing, 121 and 79 participants were recruited from the compulsory and voluntary drug detoxification center respectively in Guangdong Province. Demographic and drug-use characteristics of participants are summarized in [Table 1](#pone-0060544-t001){ref-type="table"}. Participants were typical of ATS users in China, with a predominance of single unemployed young males. The ages of the participants ranged from 18 to 52 years (mean, 31.29 years) and 269 participants (66.92%) were young people aged less than 35 years. The majority (94.50%) belonged to the Han ethnic group, 302 (75.12%) were male, 282 (71.39%) completed primary school or junior high school, 156 (39.20%) were unemployed, and 204 (50.75%) were unmarried.

10.1371/journal.pone.0060544.t001

###### Demographic characteristics and drug use history of 402 ATS Users.

![](pone.0060544.t001){#pone-0060544-t001-1}

                                                                                                          Beijing       Guangdong       Total
  ---------------------------------------------------------------------------------------------------- -------------- ------------- -------------
  Age (Years, Mean±Sd)[\*](#nt101){ref-type="table-fn"}                                                  32.727.75      29.787.14    31.29±7.52
  Age (\<35 years)[\*](#nt101){ref-type="table-fn"}                                                     124 (61.39)    145 (72.50)   269 (66.92)
  Compulsory of detoxification center[\*](#nt101){ref-type="table-fn"}                                  202 (100.00)   121 (60.50)   323 (80.35)
  Ethnicity-Han[\*](#nt101){ref-type="table-fn"}                                                        182 (90.55)    179 (98.90)   361 (94.50)
  Male gender                                                                                           144 (71.29)    158 (79.00)   302 (75.12)
  Junior high school or less                                                                            138 (69.70)    144 (73.10)   282 (71.39)
  Unemployed                                                                                             83 (41.50)    73 (36.87)    156 (39.20)
  Unmarried [\*](#nt101){ref-type="table-fn"}                                                            95 (47.03)    109 (54.50)   204 (50.75)
  Types of ATS mainly used[\*](#nt101){ref-type="table-fn"}                                                                         
  Methamphetamine                                                                                       194 (96.04)    186 (93.00)   380 (94.53)
  Ecstasy                                                                                                 4 (1.98)        0 (0)       4 (1.00)
  Magu pill                                                                                               4 (1.98)      14 (7.00)     18 (4.48)
  Administration of drug use                                                                                                        
  Inhalation administration                                                                             197 (97.52)    195 (97.50)   392 (97.51)
  Poly drug use[\*](#nt101){ref-type="table-fn"}                                                        112 (55.45)    79 (39.70)    191 (47.51)
  History of heroin use[\*](#nt101){ref-type="table-fn"}                                                 59 (29.21)     15 (7.54)    74 (18.45)
  Duration of ATS ever used ≤2 months[\*](#nt101){ref-type="table-fn"}                                   60 (30.61)    21 (10.71)    81 (20.66)
  Frequency of ATS use (Each day)                                                                       106 (52.48)    71 (35.50)    177 (44.03)
  Dose of ATS use \>0.3g/day[\*](#nt101){ref-type="table-fn"}                                           164 (81.19)    117 (58.50)   281 (69.90)
  Cessation 12 month or more                                                                             10 (4.95)     180 (90.00)   190 (47.26)
  Cause of drug use of first time[\*](#nt101){ref-type="table-fn"} [\#](#nt102){ref-type="table-fn"}                                
  Curious                                                                                                98 (48.51)    129 (64.50)   227 (56.47)
  influence by friends or peers                                                                          85 (42.08)    105 (52.50)   190 (47.26)
  Pursuit of euphoria                                                                                    34 (16.83)    92 (46.00)    126 (31.34)
  Alleviating distress or unpleasant emotions                                                            24 (11.88)    31 (15.50)    55 (13.68)
  Get energy                                                                                             27 (13.37)     16 (8.00)    43 (10.70)
  To socialize                                                                                           25 (12.38)     2 (1.00)      26 (6.47)
  Source of drug[\*](#nt101){ref-type="table-fn"} [\#](#nt102){ref-type="table-fn"}                                                 
  Illegal drug market                                                                                    95 (47.50)    170 (85.00)   265 (66.25)
  Peers or friends                                                                                       81 (40.50)    41 (20.50)    122 (30.50)
  Entertainment places                                                                                   37 (18.50)    55 (27.50)    92 (23.00)
  The person of use together[\*](#nt101){ref-type="table-fn"} [\#](#nt102){ref-type="table-fn"}                                     
  Friends                                                                                               113 (55.94)    142 (71.00)   255 (63.43)
  Girl/boy friend                                                                                        78 (38.61)    48 (24.00)    126 (31.34)
  By himself                                                                                             56 (27.72)    30 (15.00)    86 (21.39)
  Waiters in entertainment place                                                                         14 (6.93)     26 (13.00)     40 (9.95)
  Alcohol drinking                                                                                      100 (52.63)    99 (49.75)    208 (51.4)
  Cigarette smoking                                                                                     194 (96.52)    194 (97.00)   388 (96.76)
  FTND score (Years, Mean±Sd)[\*](#nt101){ref-type="table-fn"}                                           4.77±2.41      5.60±2.89      5.2±2.7
  Severe nicotine dependence (FTND ≥7)[\*](#nt101){ref-type="table-fn"}                                  44 (23.53)    76 (40.21)    124 (32.2)

there was significant difference between Beijing and Guangdong, p\<0.05.

multiple responses.

Among the 402 ATS users, methamphetamine was the main drug used in the participants and the majority (97.51%) used ATS by inhalation administration. One hundred ninety one participants (47.51%) had a history of polydrug use, indicating the use of 2 or more drugs, including methamphetamine, ecstasy, "magu" pills, ketamine, heroin and other opiates, tramadol, cocaine, cannabis, and benzodiazepine. Curious (56.47%), influence by friends or peers (47.26%), and pursuit of euphoria (31.34%) were the main causes at the first time of drug use. Illegal market (66.25%), peers or friends supply (30.50%) were the main sources of drugs, and about 23% drugs were from entertainment area. Most of ATS users (63.43%) used drug together with friends or peers, less 10% used ATS with strange waiters in entertainment areas. About 51.4% and 96.76% ATS users had behavior of alcohol drinking and cigarette smoking during the period of ATS use.

The drug users of Beijing and Guangdong Province had different special characteristics, the important features of ATS users in Beijing included high dose of ATS use, more length duration of ATS use and more proportion of poly drug use, especially more heroin abuse history than those in Guangdong. Compared with Beijing, the ATS users from Guangdong province where had more ATS Manufacturing plant had some features, including younger, lower dose of ATS use each time, less poly-drug use history, more curious and peer influence, more drugs from entertainment area ([Table 1](#pone-0060544-t001){ref-type="table"}).

The Depressive Symptoms and Associated Factors among ATS Users {#s3b}
--------------------------------------------------------------

According to BDI score, 169 participants (42.04%) had depressive symptoms, including 106 (26.37%) with moderate and 63 (15.67%) with severe depressive symptoms. [Table 2](#pone-0060544-t002){ref-type="table"} listed the factors which were associated with moderate or severe depressive symptoms (BDI-13 score ≥8) by univariate logistic regression analysis, including age, gender, area, occupation, duration of ATS ever used, cessation of drug use, dose of ATS use, relapse history, using ATS together with entertainment venues waiter, sleep disorder, hypomnesia and promiscuity after using ATS, cigarette smoking, nicotine dependence and alcohol drinking. The multiple logistic regression showed that the high dose for ATS use, history of ATS use relapse were associated with depressive symptoms, the adjusted odds ratios (OR) was 2.62, (95% CI: 1.45--4.74) and 2.01 (95% CI: 1.18--3.42) respectively. The cessation 12 month or more have less risk of depressive symptoms than the current users, the OR was 0.46 (95% CI: 0.24--0.91), and the ATS users reporting nicotine dependence and alcohol drinking were significantly have more risk of depressive symptoms for 3.11 (1.83--5.28) and 2.22 (1.35--3.65) times than those without these behaviors ([Table 3](#pone-0060544-t003){ref-type="table"}).

10.1371/journal.pone.0060544.t002

###### Bivariate analysis of risk factors for depressive symptoms among ATS Users.
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                                                                       Depression (BDI-13 score≥8)                 
  ------------------------------------------------------------- ----- ----------------------------- ------- ------ ----------------------------------------------
  Age (years)                                                                                                      
  ≤34                                                            269               102               37.92   1.0   
  ≥35                                                            133               67                50.38   1.66   1.09--2.53[\*](#nt103){ref-type="table-fn"}
  Gender                                                                                                           
  Female                                                         100               20                20.00   1.0   
  Male                                                           302               149               49.34   3.87   2.26--6.64[\*](#nt103){ref-type="table-fn"}
  Area                                                                                                             
  Beijing                                                        202               71                35.15    1    
  Guangdong                                                      200               98                49.00   1.77   1.19--2.65[\*](#nt103){ref-type="table-fn"}
  Type of drug detoxification center                                                                               
  Voluntary                                                      79                39                49.37    1    
  Compulsory                                                     323               130               40.25   0.69                    0.42--1.13
  Nationality                                                                                                      
  Han                                                            361               155               42.94   1.0   
  Minority                                                       21                 8                38.10   0.82                    0.33--2.02
  Marital status                                                                                                   
  Unmarried                                                      204               77                37.75   1.0   
  Cohabitating                                                   17                 7                41.18   1.13                    0.55--2.30
  Married                                                        144               70                48.61   1.56                    1.01--2.40
  Divorced or widowed                                            37                15                40.54   1.16                    0.42--3.16
  Education                                                                                                        
  Junior high school or less                                     282               124               43.97   1.0   
  Senior high school or more                                     113               41                36.28   0.73                    0.46--1.14
  Occupation                                                                                                       
  Unemployed                                                     156               42                26.92   1.0   
  Employed                                                       242               125               51.65   2.90   1.88--4.48[\*](#nt103){ref-type="table-fn"}
  Duration of ATS ever used (months)                                                                               
  0--2                                                           81                26                32.10   1.0   
  ≥3                                                             311               138               44.37   1.69   1.01--2.83[\*](#nt103){ref-type="table-fn"}
  Period of drug use                                                                                               
  Continue use                                                   190               91                47.89   1.0   
  Cessation 1--12 month                                          131               54                41.22   1.67                    0.92--3.01
  Cessation 12 month or more                                     81                24                29.63   2.18   1.25--3.80[\*](#nt103){ref-type="table-fn"}
  Dose of ATS use (g/day)                                                                                          
  ≤0.3                                                           121               31                25.62   1.0   
  \>0.3                                                          281               138               49.11   2.80   1.75--4.49[\*](#nt103){ref-type="table-fn"}
  History of relapse                                                                                               
  No                                                             264               98                37.12   1.0   
  Yes                                                            137               71                51.82   1.82   1.20--2.77[\*](#nt103){ref-type="table-fn"}
  Polydrug use                                                                                                     
  No                                                             210               83                39.52   1.0   
  Yes                                                            191               86                45.03   1.25                    0.84--1.86
  Use ATS together with entertainment venues waiter                                                                
  No                                                             362               145               40.06   1.0   
  Yes                                                            40                24                60.00   2.25   1.15--4.37[\*](#nt103){ref-type="table-fn"}
  Sleep disorders frequency after using ATS                                                                        
  Never or occasionally                                          150               43                28.67   1.0   
  Each time                                                      214               98                45.79   2.10   1.35--3.28[\*](#nt103){ref-type="table-fn"}
  Hypomnesia after using ATS                                                                                       
  Never                                                          112               24                21.43   1.0   
  Mild                                                           170               70                41.18   2.57   1.49--4.43[\*](#nt103){ref-type="table-fn"}
  Severe                                                         115               74                64.35   6.82   3.67--11.95[\*](#nt103){ref-type="table-fn"}
  History of promiscuity after use ATS                                                                             
  No                                                             345               135               39.13   1.0   
  Yes                                                            57                34                59.65   2.30   1.30--4.07[\*](#nt103){ref-type="table-fn"}
  Cigarette smoking                                                                                                
  No                                                             17                 2                11.76   1.0   
  Yes                                                            364               157               43.13   5.69   1.28--25.24[\*](#nt103){ref-type="table-fn"}
  The change of number of cigarette smoking after drug taking                                                      
  No change                                                      167               52                31.14   1.0   
  Decrease                                                       32                16                50.00   2.21   1.03--4.76[\*](#nt103){ref-type="table-fn"}
  Increase                                                       177               96                54.24   2.62   1.69--4.07[\*](#nt103){ref-type="table-fn"}
  Nicotine dependence (FTND score)                                                                                 
  \<7                                                            256               83                32.42   1.0   
  ≥7                                                             120               79                65.83   4.02   2.54--6.36[\*](#nt103){ref-type="table-fn"}
  Alcohol Drinking                                                                                                 
  No                                                             190               64                33.68   1.0   
  Yes                                                            199               102               51.26   2.07   1.37--3.12[\*](#nt103){ref-type="table-fn"}

: there was significant difference, p\<0.05.

:95% confidential interval (95%CI).

10.1371/journal.pone.0060544.t003

###### Multiple Logistic regression of risk factors for depressive symptoms among ATS Users.
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  Characteristics                     Adjusted OR for (BDI-13 score≥8)     95%CI[\#](#nt106){ref-type="table-fn"}
  ---------------------------------- ---------------------------------- ---------------------------------------------
  Dose of ATS use (g/day)                                               
  ≤0.3                                              1.0                 
  \>0.3                                             2.62                 1.45--4.74[\*](#nt105){ref-type="table-fn"}
  History of relapse                                                    
  No                                                 1                  
  Yes                                               2.01                 1.18--3.42[\*](#nt105){ref-type="table-fn"}
  Period of drug use                                                    
  Continue use                                      1.0                 
  Cessation 1--12 month                             0.57                                 0.32--1.04
  Cessation 12 month or more                        0.46                 0.24--0.91[\*](#nt105){ref-type="table-fn"}
  Nicotine dependence (FTND score)                                      
  \<7                                               1.0                 
  ≥7                                                3.11                 1.83--5.28[\*](#nt105){ref-type="table-fn"}
  Alcohol Drinking                                                      
  No                                                1.0                 
  Yes                                               2.22                 1.35--3.65[\*](#nt105){ref-type="table-fn"}

there was significant difference, p\<0.05.

95% confidential interval (95%CI).

Discussion {#s4}
==========

This cross-sectional study found some characteristics of drug use and reported a high rate (42%) of depressive symptoms among ATS users in Beijing and Guangdong Province, China. We showed additional information about the factors associated with depressive symptoms in ATS users. These findings provide evidence of the development strategies for prevention and treatment of ATS use and associated depressive symptoms in this population.

In this study, we found some features of ATS users in Guangdong Province, where is the south-eastern littoral and rich province and close to Hong Kong and Macao. Resent years, a large number of new ATS users appears in Guangdong Province, where became one of the provinces with top numbers of registered ATS users [@pone.0060544-United2]. The findings indicated that the ATS users in Guangdong Province were younger and vulnerable by peers and friends than those in Beijing, which suggested that more attention should be paid to health education about ATS use prevention in the areas of ATS abuse spread including Guangdong Province.

Depressive symptoms were common in ATS users and the rate of moderate or severe depression was high (42%). This finding which the co-occurrence of high level of depressive symptoms was common in ATS users, was approved by studies from China and other countries [@pone.0060544-Zhang1], [@pone.0060544-Darke1]. Some studies showed that the prevalence of depression ranged from 28%-80% among ATS users or ATS dependent patients seeking treatment [@pone.0060544-Conway1], [@pone.0060544-Hall1], [@pone.0060544-Zhang1], [@pone.0060544-Darke1]. This study supports the findings of these authors and substantially broadens the reference population.

The multiple logistic regression analysis showed that high dose of ATS use, history of relapse, current ATS use, nicotine dependence and alcohol drinking were associated with moderate or severe depressive symptoms. The study showed that ATS users with high dose of drug use, which was related with higher frequency of drug use, have high risk of depression. The familiar finding was observed in a Thailand study that indicated frequent methamphetamine use was associated with depressive symptoms [@pone.0060544-Celentano1]. This study indicated that ATS users of cessation 12 month or longer period had significantly less risk of depressive symptoms than participants who continued to use ATS and a similar finding was observed from a prospective cohort study [@pone.0060544-Sutcliffe1]. The ATS users with a history of relapse have more depressive symptoms, because the history of relapse was associated with more severe degree of ATS dependence. These findings provide evidence for that the cessation and reduction of ATS use and relapse prevention were helpful to decrease the burden of ATS use and related mental health in this population.

Many studies showed that the depression and smoking or drinking have complicated bidirectional relationship [@pone.0060544-McCarty1], [@pone.0060544-Tsuang1]. Research showed that cigarette smoking were significantly related to later development of major depression and other mental disorders, and inversely, depressed smoker less likely to have quit compared with non-depressed smokers [@pone.0060544-AjdacicGross1], [@pone.0060544-Anda1]. Studies showed that depressive symptoms were positively associated with one year alcohol use among adolescent [@pone.0060544-McCarty1]. In this study, we found that nicotine dependence and alcohol drinking during period of drug use increased and aggravated the degree of depression among ATS users. The findings indicated that reduction and treatment of nicotine dependence and alcohol drinking during ATS treatment may improve the mental health among the ATS users.

This survey showed that ATS users receiving more education have less likely to depressive symptoms indicated that the health education is helpful to decrease the ATS use and improve the mental health among ATS users. In this study, the majority participants were from compulsory drug detoxification center, we want to know whether the depression status was influenced by type of drug detoxification center. The finding that there was no difference of depressive symptoms among ATS users between compulsory and voluntary drug detoxification centers in this analysis, indicated that the method of recruitment sample had not effect on the result of depression status among ATS users in this paper. The result, the rate of depressive symptoms in male was higher than that of female in the univariate analysis, was bewildering and the result was not consistent with other study [@pone.0060544-Zhang1]. The possible reason is the female had less dose (0.29g/time) of drug use than that in male (0.39g/time) in this sample. However, the gender factor did not enter the final model in multiple logistic regression. So the gender difference of depressive symptoms among ATS users needs further investigation with rigorous design.

There were several limitations of cross-sectional investigation and non-random sampling methods in this study which would cause the difficulty in extrapolating the results. First, our samples were recruited from compulsory and voluntary drug detoxification and rehabilitation centers and should not be considered representative of all ATS users in these areas. On the other hand, this is a retrospective study and cannot avoid recall bias for the drug use history. Third, the proportion of current ATS use between the sample of Beijing and Guangdong is different, which have influence on the relationship between factors and depressive symptoms. Finally, the small sample size and limited geographic coverage might limit the detection of potentially associated risk factors. More well-designed community-based epidemiologic studies with larger sample sizes and larger geographic coverage should be conducted to validate the prevalence rate of depressive symptoms and explore the extensive risk factors using other recruitment methods.

Conclusion {#s5}
==========

The findings indicated a higher prevalence of depressive symptoms among ATS users, and identified possible factors associated with depressive symptoms, including current ATS use, higher dose of ATS use, history of relapse, nicotine dependence, and alcohol drinking. Our study provides information for the treatment and management strategies for ATS use and associated mental health in this population for the future.
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